Tech Company Financing Transactions
DermTech Funding Round
On 8/21/2013, DermTech announced $5.6 million in Series B funding from Jacobs Investments and private investors.
Transaction Overview
Company Name
Announced On
8/21/2013
Transaction Type
Venture Equity
Amount
$5,600,000
Round
Series B
Investors
Jacobs Investments (Lead Investor)
Proceeds Purpose
Proceeds from the financing will be used to fund further development, complete commercial validation of assays, and achieve the necessary laboratory accreditation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11099 North Torrey Pines Rd. 100
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
DermTech in La Jolla, CA develops qPCR assays and diagnostic aides for skin samples collected non-invasively to detect melanoma and skin cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Dobak
Chief Medical Officer
Burkhard Jansen
Chief Scientific Officer
Zuxu Yao
VP - Sales
Sarah Dion
Browse more venture capital transactions:
Prev: 8/20/2013: Versify Solutions venture capital transaction
Next: 8/21/2013: eNeura venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs